asco@alo33:161292 JSONTXT

{"project":"ASCO_abstracts","denotations":[{"id":"T1","span":{"begin":454,"end":462},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":1214,"end":1217},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"0005070"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"0001162"}],"text":" Background: Despite increasing interest in and efforts to improve its management, pain remains poorly controlled in nearly half of all patients ith cancer. Pain is among the most distressing and disabling sequelae of cancer and its related treatments and remains poorly managed. The prevalence of cancer-related pain has ranged from 14 percent to 100 percent in surveys. We aim to determine the incidence and costs of hospital admission associated ith Neoplasm related pain NRP using a nationally representative database. Methods: National Inpatient Sample NIS accounts for 20 percent of all U.S hospitalizations. We revieed the NIS for all hospitalizations in hich NRP ICD9 code 338.3 as the principal discharge diagnosis during the period from 2007-2013 .We then analyzed changes in temporal trends of incidence, length of stay, costs and in-hospital mortality utilizing Cochrane-Armitage test. Results: There ere 140,999 primary admissions for NRP during the study period. In-hospital mortality for the cohort as 8.5 percent n= 12,040 . Hospitalization ith NRP primary diagnosis increased significantly from 12,765 cases to 23,025 p lt 0.01 . This trend as similar but much significant hen the same ICD code as used for both primary and secondary discharge diagnosis 48,473 cases in 2007 to 107,345 cases in 2013 p lt 0.0001 .There as a significant reduction in in-hospital mortality over a period of 6 years from 9.65 percent in 2007 to 7.62 percent in 2013 p lt 0.01 . In addition, during this period the mean hospital charges increased significantly from 27,227 after adjusting for inflation per admission in 2007 to 33,835 per admission in 2013 p lt 0.001 , hereas the ;national burden ; increased from 308 million to 777 million during the study period P lt 0.01 ithout any significant change in length of hospitalization during the same period. Conclusions: There is significant increase in the hospitalization and cost for cancer related pain. This could be partly because of previous under-reporting, increased aareness, healthcare seeking behavior and increasing use of procedural techniques to alleviate pain. More studies are needed to assess factors associated ith increased hospitalization.,J Clin Oncol 34, 2016 suppl; abstr 10138 00:00.0,Patient and Survivor Care \n"}